Abstract | BACKGROUND: METHODS: RESULTS: Three randomized controlled trials evaluating 219 participants were included. Two were studies on vascular dementia, and the other was on Alzheimer's dementia. There was no difference between Choto-san and placebo in terms of short-term dichotomous judgement of improvement, but Choto-san was more effective than placebo in terms of short-term improvement of cognitive function as measured by continuous outcomes. Also, dropouts judged it to be acceptable. However, the results were imprecise and/or heterogeneous. The number of participants included in the analysis was small (n = 199 in the primary analysis) and sometimes inconsistent, as indicated by the large I 2 (72% in the primary analysis). CONCLUSION: Low-quality evidence was suggestive of Choto-san's efficacy for vascular dementia, but the present results may be overestimated. Studies with a larger sample size and conducted over longer periods should be performed. Regardless, Choto-san can be one of the choices for the treatment of vascular dementia as it is well tolerated.
|
Authors | Hissei Imai, Nozomi Takeshima, Haruhiko Oda, Peiyao Chen, Etsuko Sawada, Toshiaki A Furukawa |
Journal | Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
(Psychogeriatrics)
Vol. 17
Issue 6
Pg. 466-478
(Nov 2017)
ISSN: 1479-8301 [Electronic] England |
PMID | 28589702
(Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
|
Copyright | © 2017 Japanese Psychogeriatric Society. |
Chemical References |
- Drugs, Chinese Herbal
- Placebos
- Plant Extracts
- choto-san
|
Topics |
- Cognition Disorders
(drug therapy)
- Dementia
(drug therapy, metabolism)
- Drugs, Chinese Herbal
(therapeutic use)
- Humans
- Placebos
(therapeutic use)
- Plant Extracts
- Plants, Medicinal
- Randomized Controlled Trials as Topic
- Treatment Outcome
|